{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:58:13Z","timestamp":1772751493546,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10067-014-2812-y","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T04:22:53Z","timestamp":1414988573000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Experience with alendronate treatment for 7\u00a0years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures"],"prefix":"10.1007","volume":"35","author":[{"given":"Jun","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"2812_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"2812_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077\u20132082","journal-title":"JAMA"},{"issue":"1","key":"2812_CR3","volume":"23","author":"GA Wells","year":"2008","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23(1), CD001155","journal-title":"Cochrane Database Syst Rev"},{"key":"2812_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis\u2014executive summary. Arch Osteoporos 7:3\u201320","journal-title":"Arch Osteoporos"},{"key":"2812_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1056\/NEJM200008313430902","volume":"343","author":"E Orwoll","year":"2000","unstructured":"Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604\u2013610","journal-title":"N Engl J Med"},{"key":"2812_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00044011-200424060-00003","volume":"24","author":"PD Miller","year":"2004","unstructured":"Miller PD, Schnitzer T, Emkey R, Orwoll E, Rosen C, Ettinger M, Vandormael K, Daifotis A (2004) Weekly oral alendronic acid in male osteoporosis. Clin Drug Investig 24:333\u2013341","journal-title":"Clin Drug Investig"},{"key":"2812_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00296-003-0388-y","volume":"24","author":"JD Ringe","year":"2004","unstructured":"Ringe JD, Dorst A, Faber H, Ibach K (2004) Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Rheumatol Int 24:110\u2013113","journal-title":"Rheumatol Int"},{"key":"2812_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00223-002-1085-7","volume":"73","author":"S Gonnelli","year":"2003","unstructured":"Gonnelli S, Cepollaro C, Montagnani A, Bruni D, Caffarelli C, Breschi M, Gennari L, Gennari C, Nuti R (2003) Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 73:133\u2013139","journal-title":"Calcif Tissue Int"},{"key":"2812_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","volume":"26","author":"JD Ringe","year":"2006","unstructured":"Ringe JD, Faber H, Farahmand P, Dorst A (2006) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26:427\u2013431","journal-title":"Rheumatol Int"},{"key":"2812_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00774-008-0024-8","volume":"27","author":"T Majima","year":"2009","unstructured":"Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2009) Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study. J Bone Miner Metab 27:168\u2013174","journal-title":"J Bone Miner Metab"},{"key":"2812_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2147\/TCRM.S15812","volume":"6","author":"J Iwamoto","year":"2010","unstructured":"Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H (2010) Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Ther Clin Risk Manag 6:593\u2013600","journal-title":"Ther Clin Risk Manag"},{"key":"2812_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0278-2391(09)01877-1","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J Oral Maxillofac Surg 67:2\u201312","journal-title":"J Oral Maxillofac Surg"},{"key":"2812_CR13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMc0707493","volume":"358","author":"BA Lenart","year":"2008","unstructured":"Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304\u20131306","journal-title":"N Engl J Med"},{"key":"2812_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s001980050214","volume":"10","author":"M Shiraki","year":"1999","unstructured":"Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, Kaneda K, Minaguchi H, Inoue T, Morii H, Tomita A, Yamamoto K, Nagata Y, Nakashima M, Orimo H (1999) A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int 10:183\u2013192","journal-title":"Osteoporos Int"},{"key":"2812_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00774-005-0616-5","volume":"23","author":"S Uchida","year":"2005","unstructured":"Uchida S, Taniguchi T, Shimizu T, Kakikawa T, Okuyama K, Okaniwa M, Arizono H, Nagata K, Santora AC, Shiraki M, Fukunaga M, Tomomitsu T, Ohashi Y, Nakamura T (2005) Therapeutic effects of alendronate 35\u00a0mg once weekly and 5\u00a0mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab 23:382\u2013388","journal-title":"J Bone Miner Metab"},{"key":"2812_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s007740050038","volume":"16","author":"H Orimo","year":"1998","unstructured":"Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y (1998) Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 16:139\u2013150","journal-title":"J Bone Miner Metab"},{"key":"2812_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"2812_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borsgtrom F, de Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581\u2013589","journal-title":"Osteoporos Int"},{"key":"2812_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1359\/jbmr.2003.18.8.1547","volume":"18","author":"S Fujiwara","year":"2003","unstructured":"Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547\u20131553","journal-title":"J Bone Miner Res"},{"key":"2812_CR20","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929\u20131936","journal-title":"Lancet"},{"key":"2812_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00774-004-0590-3","volume":"23","author":"J Iwamoto","year":"2005","unstructured":"Iwamoto J, Takeda T, Sato Y, Uzawa M (2005) Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with one-year response of lumbar bone mineral density to alendronate in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab 23:238\u2013242","journal-title":"J Bone Miner Metab"},{"key":"2812_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1010054924085","volume":"2","author":"E Seeman","year":"2001","unstructured":"Seeman E (2001) Unresolved issues in osteoporosis in men. Rev Endocr Metab Disord 2:45\u201364","journal-title":"Rev Endocr Metab Disord"},{"key":"2812_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-2362.1992.tb01503.x","volume":"22","author":"H Resch","year":"1992","unstructured":"Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R (1992) Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Investig 22:542\u2013545","journal-title":"Eur J Clin Investig"},{"key":"2812_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/8756-3282(94)90790-0","volume":"15","author":"CA Sharp","year":"1994","unstructured":"Sharp CA, Worsfold M, Rowlands PR, Davie MW (1994) Accurate prediction of spinal osteoporosis in men using a biochemical measure of collagen balance. Bone 15:243","journal-title":"Bone"},{"issue":"Suppl","key":"2812_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF03026329","volume":"23","author":"S Fujiwara","year":"2005","unstructured":"Fujiwara S (2005) Epidemiology of osteoporosis in Japan. J Bone Miner Metab 23(Suppl):81\u201383","journal-title":"J Bone Miner Metab"},{"key":"2812_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00223-011-9499-8","volume":"89","author":"R Rizzoli","year":"2011","unstructured":"Rizzoli R, Reginster JY, Boonen S, Br\u00e9art G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C (2011) Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int 89:91\u2013104","journal-title":"Calcif Tissue Int"},{"key":"2812_CR27","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"key":"2812_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00774-007-0771-y","volume":"25","author":"K Imai","year":"2007","unstructured":"Imai K, Yamamoto S, Anamizu Y, Horiuchi T (2007) Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy. J Bone Miner Metab 25:333\u2013336","journal-title":"J Bone Miner Metab"},{"key":"2812_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00198-008-0813-x","volume":"20","author":"E Seeman","year":"2009","unstructured":"Seeman E (2009) To stop or not to stop, that is the question. Osteoporos Int 20:187\u2013195","journal-title":"Osteoporos Int"},{"key":"2812_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jbmr.1542","volume":"27","author":"JE Compston","year":"2012","unstructured":"Compston JE, Bilezikian JP (2012) Bisphosphonate therapy for osteoporosis: the long and short of it. J Bone Miner Res 27:240\u2013242","journal-title":"J Bone Miner Res"},{"key":"2812_CR31","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR (2006) Effects of continuing or stopping alendronate after 5\u00a0years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296:2927\u20132938","journal-title":"JAMA"},{"key":"2812_CR32","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1056\/NEJMp1202619","volume":"366","author":"M Whitaker","year":"2012","unstructured":"Whitaker M, Guo J, Kehoe T, Benson G (2012) Bisphosphonates for osteoporosis\u2014where do we go from here? N Engl J Med 366:2048\u20132051","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s10067-021-05796-3","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"record-id":"29915"},{"DOI":"10.1007\/s10067-014-2812-y","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000}},{"DOI":"10.1007\/s10067-021-05796-3","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-014-2812-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2812-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:02:11Z","timestamp":1772708531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-014-2812-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2812"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2812-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]},"assertion":[{"value":"17 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ExpressionOfConcern","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Editorial Expression of Concern to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-021-05796-3","URL":"https:\/\/doi.org\/10.1007\/s10067-021-05796-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}